Clinical trial
Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic…
NCT00343369 · Universitätsklinikum Hamburg-Eppendorf, Other · Unknown status
Key facts
| NCT number | NCT00343369 |
|---|---|
| Title | Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia |
| Official title | Multicentric Study for the Treatment of Children With Acute Lymphoblastic Leukemia |
| Lead sponsor | Universitätsklinikum Hamburg-Eppendorf, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug, Radiation |
| Interventions | asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, mercaptopurine, methotrexate, pegaspargase, prednisolone and 4 more |
| Enrollment | 550 |
| Start date | Jan 1, 2003 |
| First posted | Jun 23, 2006 |
| Last update posted | Aug 26, 2013 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: